Whipplewood Advisors, LLC Glaukos Corp Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 7 shares of GKOS stock, worth $1,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$1,080% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
349Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.24 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$906 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$337 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$302 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$253 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.35B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...